Cellebrite DI Ltd.
NASDAQ Global SelectTotal Valuation
Cellebrite DI Ltd. carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at -419.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.09B |
| Enterprise Value | -419.30M |
Share Statistics
Cellebrite DI Ltd. currently has 250.79M shares outstanding.
| Shares Outstanding | 250.79M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Cellebrite DI Ltd. maintains a current ratio of 1.62, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.62 |
| Quick Ratio | 1.52 |
| Debt / Equity | 4.32 |
| Debt / EBITDA | 0.30 |
| Interest Coverage | N/A |
Financial Efficiency
Cellebrite DI Ltd. posts a return on equity of 12.42 and a return on invested capital of 8.79.
| Return on Equity (ROE) | 12.42 |
| Return on Assets (ROA) | 6.60 |
| Return on Invested Capital (ROIC) | 8.79 |
| Return on Capital Employed (ROCE) | 11.85 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.78 |
Taxes
Over the trailing twelve months, Cellebrite DI Ltd. has paid 16.62M in income taxes, reflecting an effective tax rate of 22.05.
| Income Tax | 16.62M |
| Effective Tax Rate | 22.05 |
Stock Price Statistics
Cellebrite DI Ltd.'s stock has gained approximately 404.67308% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | 404.67308% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached 78.43M, while operating income came in at 55.86M.
| Revenue | 514.29M |
| Gross Profit | 426.66M |
| Operating Income | 55.86M |
| Pretax Income | 75.38M |
| Net Income | 58.76M |
| EBITDA | 78.43M |
| EBIT | 55.86M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Cellebrite DI Ltd. holds 442.53M in cash and equivalents against 23.23M in total debt, resulting in a net debt position of -141.25M. Total book value stands at 538.10M, with working capital of 225.47M providing operational flexibility.
| Cash & Cash Equivalents | 442.53M |
| Total Debt | 23.23M |
| Net Debt | -141.25M |
| Equity (Book Value) | 538.10M |
| Book Value Per Share | 2.15 |
| Working Capital | 225.47M |
Cash Flow
Cellebrite DI Ltd. produced 157.56M in operating cash flow over the past twelve months.
| Operating Cash Flow | 157.56M |
| Capital Expenditures | -29.01M |
| Free Cash Flow | 128.55M |
| FCF Per Share | N/A |
Margins
Cellebrite DI Ltd. operates with a gross margin of 82.96, reflecting its pricing power and cost economics. The operating margin of 10.86 and net profit margin of 11.43 provide insight into operational efficiency.
| Gross Margin | 82.96 |
| Operating Margin | 10.86 |
| Pretax Margin | 14.66 |
| Profit Margin | 11.43 |
| EBITDA Margin | 15.25 |
Scores
Cellebrite DI Ltd. posts an Altman Z-Score of 1.16, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.16 |